These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Beneficial effects of Angiotensin II receptor blockers in brain disorders. Saavedra JM Pharmacol Res; 2017 Nov; 125(Pt A):91-103. PubMed ID: 28711402 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain. Saavedra JM; Benicky J; Zhou J Cell Mol Neurobiol; 2006; 26(7-8):1099-111. PubMed ID: 16636899 [TBL] [Abstract][Full Text] [Related]
7. Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease. Saavedra JM Cell Mol Neurobiol; 2016 Mar; 36(2):259-79. PubMed ID: 26993513 [TBL] [Abstract][Full Text] [Related]
8. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Villapol S; Balarezo MG; Affram K; Saavedra JM; Symes AJ Brain; 2015 Nov; 138(Pt 11):3299-315. PubMed ID: 26115674 [TBL] [Abstract][Full Text] [Related]
9. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Saavedra JM Cell Mol Neurobiol; 2005 Jun; 25(3-4):485-512. PubMed ID: 16075377 [TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases. Mogi M; Horiuchi M Geriatr Gerontol Int; 2013 Jan; 13(1):13-8. PubMed ID: 22726823 [TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin II receptor blockers on dementia. Mogi M; Horiuchi M Hypertens Res; 2009 Sep; 32(9):738-40. PubMed ID: 19727113 [TBL] [Abstract][Full Text] [Related]
12. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review. Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important? Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009 [TBL] [Abstract][Full Text] [Related]
14. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT Justin A; Divakar S; Ramanathan M Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550 [TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage. Horiuchi M; Mogi M Br J Pharmacol; 2011 Jul; 163(6):1122-30. PubMed ID: 21175580 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Benicky J; Sánchez-Lemus E; Honda M; Pang T; Orecna M; Wang J; Leng Y; Chuang DM; Saavedra JM Neuropsychopharmacology; 2011 Mar; 36(4):857-70. PubMed ID: 21150913 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers and cerebral protection in stroke. Thöne-Reineke C; Steckelings UM; Unger T J Hypertens Suppl; 2006 Mar; 24(1):S115-21. PubMed ID: 16601564 [TBL] [Abstract][Full Text] [Related]
19. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence. Kangussu LM; Marzano LAS; Souza CF; Dantas CC; Miranda AS; Simões E Silva AC Protein Pept Lett; 2020; 27(6):463-475. PubMed ID: 31849284 [TBL] [Abstract][Full Text] [Related]
20. Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation. Wang J; Pang T; Hafko R; Benicky J; Sanchez-Lemus E; Saavedra JM Neuropharmacology; 2014 Apr; 79():249-61. PubMed ID: 24316465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]